RT @sitcancer: #JITC Case Report: Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-R…
#JITC Case Report: Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series https://t.co/NEnZzbbKYO https://t
RT @sitcancer: #JITC Case Report: Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-R…
#JITC Case Report: Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series https://t.co/NEnZzbbKYO https://t
RT @sitcancer: #JITC Case Report: Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-R…
#JITC Case Report: Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series https://t.co/NEnZzbbKYO https://t
RT @sitcancer: New #JITC Case Report: Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with…
RT @sitcancer: New #JITC Case Report: Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with…
RT @sitcancer: New #JITC Case Report: Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with…
RT @sitcancer: New #JITC Case Report: Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with…
RT @thenasheffect: Our recent paper regarding cutaneous adverse reaction patterns with ICI and targeted therapy in melanoma.@sitcancer @E…
Our recent paper regarding cutaneous adverse reaction patterns with ICI and targeted therapy in melanoma.@sitcancer @EladSharonMD Wonderful collborating with @UNC_Lineberger . Not much data at all on this out there! Thank you @jitc
RT @sitcancer: New #JITC Case Report: Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with…
New #JITC Case Report: Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series https://t.co/NEnZzbbKYO https